121 related articles for article (PubMed ID: 37877291)
21. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
22. Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.
Elkamhawy A; Woo J; Nada H; Angeli A; Bedair TM; Supuran CT; Lee K
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269684
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
25. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
26. Benzenesulfonamides functionalized with triazolyl-linked pyrazoles possess dual cathepsin B and carbonic anhydrase inhibitory action.
Siwach K; Arya P; Vats L; Sharma V; Giovannuzzi S; Raghav N; Supuran CT; Sharma PK
Arch Pharm (Weinheim); 2024 Jun; ():e2400114. PubMed ID: 38900588
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII.
George RF; Said MF; Bua S; Supuran CT
Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473
[TBL] [Abstract][Full Text] [Related]
28. Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII.
El-Damasy AK; Kim HJ; Nocentini A; Seo SH; Eldehna WM; Bang EK; Supuran CT; Keum G
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2154603. PubMed ID: 36728712
[TBL] [Abstract][Full Text] [Related]
29. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.
Carradori S; Secci D; De Monte C; Mollica A; Ceruso M; Akdemir A; Sobolev AP; Codispoti R; De Cosmi F; Guglielmi P; Supuran CT
Bioorg Med Chem; 2016 Mar; 24(5):1095-105. PubMed ID: 26810710
[TBL] [Abstract][Full Text] [Related]
30. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
Grandane A; Tanc M; Zalubovskis R; Supuran CT
Bioorg Med Chem Lett; 2014 Mar; 24(5):1256-60. PubMed ID: 24518190
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
33. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII.
Buran K; Bua S; Poli G; Önen Bayram FE; Tuccinardi T; Supuran CT
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857344
[TBL] [Abstract][Full Text] [Related]
34. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
[TBL] [Abstract][Full Text] [Related]
35. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
36. Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors.
Ewies EF; Sabry E; Bekheit MS; Fouad MA; Vullo D; Supuran CT
Drug Dev Res; 2022 Sep; 83(6):1281-1291. PubMed ID: 35706360
[TBL] [Abstract][Full Text] [Related]
37. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2018 Sep; 157():28-36. PubMed ID: 30071407
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Newaskar V; Angeli A; Sigalapalli DK; Goud NS; Chirra H; Shaik AB; Arifuddin M; Supuran CT
Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200232. PubMed ID: 36122182
[TBL] [Abstract][Full Text] [Related]
40. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
